News

Quotient Sciences Acquires Arcinova, the UK-Based Contract Development and Manufacturing Organization

Quotient Sciences, the drug development and manufacturing accelerator, announced that it has acquired Arcinova, the U.K.-based multiservice contract development and manufacturing organization (CDMO). With over 40 years of experience and 160 employees, Arcinova provides drug substance, drug product and bioanalysis services to over 200 pharma and biotech customers worldwide.

Quotient Sciences wins multiple categories in 2021 CRO Leadership Awards

Content: Quotient has been recognized with multiple 2021 CRO Leadership Awards, including two Champion Awards. The CRO Leadership Awards recognizes top performing outsourcing organizations in the drug development arena. Quotient received leadership awards in five of the overall six categories.

Quotient featured in Drug Development & Delivery's Solubility Special Feature Report

Quotient Sciences was featured in Drug Development & Delivery's Special Feature article entitled: "Improving Bioavailability & Solubility: Each Molecule Is Unique."

Quotient Sciences Recognized as Top Pharma and Life Sciences Outsourcing Company

Quotient Sciences, a global drug development and manufacturing organization has been recognized as a “Top Pharma and Life Sciences Outsourcing Services Company in the UK for 2020” by PharmaTech Outlook magazine.

ANA Therapeutics and Quotient Sciences Announce Partnership to Manufacture Niclosamide Drug Candidate as a Potential Treatment for COVID-19

Quotient and ANA Therapeutics announce partnership to develop drug candidate, ANA001 (niclosamide capsules) as a potential treatment for COVID-19.

Quotient Sciences Completes Million Dollar Pharmacy Expansion at Miami Clinic

State-of-the-Art Compounding Pharmacy Will Accelerate Early Development Programs

Quotient Sciences and CytoAgents Accelerate Potential Treatment for COVID-19 Cytokine Storm

A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials announced by Quotient Sciences and CytoAgents.

Drug Substance Formulation Development Bioanalysis Clinical Trial Manufacturing Commercial Manufacturing Clinical Pharmacology Data Sciences Drug Development Consulting

Ask us a question

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.